Crossmark

Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece

Crossref DOI link: https://doi.org/10.1016/j.vacun.2023.05.005

Published Print: 2023-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Galanis, Petros

Katsiroumpa, Aglaia

Vraka, Irene

Chrysagi, Vanessa

Siskou, Olga

Konstantakopoulou, Olympia

Katsoulas, Theodoros

Gallos, Parisis

Kaitelidou, Daphne
License Information

Text and Data Mining valid from 2023-07-01

stm-asf valid from 2023-07-01

stm-asf valid from 2023-07-01

stm-asf valid from 2023-07-01

stm-asf valid from 2023-07-01

stm-asf valid from 2023-07-01
More Information

This article is maintained by: Elsevier

Article Title: Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece

Journal Title: Vacunas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.vacun.2023.05.005

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.